Cytokinetics, Incorporated · NASDAQ:CYTK
Lee Sung sold 3,134 Cytokinetics, Incorporated shares (Form 4)
Traded Jun 29, 2026 · Filed Jun 29, 2026
On Jun 29, 2026, Lee Sung (EVP, Chief Financial Officer) sold 3,134 Cytokinetics, Incorporated shares at US$85.00 for US$266K under a trading plan, leaving 63,221 shares. Filed Jun 29, 2026 (Form 4).
- Sold
- 3,134 shares
- Price
- US$85.00
- Value
- US$266K
- Holding after
- 63,221 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Option exercise | 188 | US$44.36 | 63,409 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 822 | US$44.36 | 64,231 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 1,113 | US$48.51 | 65,344 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 823 | US$44.36 | 66,355 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 3,134 | US$85.00 | 63,221 | Direct |
Source
Related
- Cytokinetics, Incorporated
- Lee Sung
- Cytokinetics, Incorporated shareholders
- Form 4 · Lee Sung · Jul 2, 2026
- Form 4 · Lee Sung · Jun 29, 2026
- Form 4 · Lee Sung · May 5, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026